07/20/2023
“At Veranova, we are looking to build a great company that matters.”
Find out how Veranova will continue to manage complexity with confidence in this Q&A with our CEO, Mike Riley.
Here, Mike shares his priorities, his plans to foster a culture of excellence, and his approach to partnerships within the pharmaceutical landscape. He discusses the importance of collaboration, transparency, and problem-solving to deliver exceptional value to customers. Read now!
In May, Veranova announced the appointment of Mike Riley as the company’s Chief Executive Officer. Mr. Riley has extensive knowledge of the life science and CDMO industry, having spent nearly 19 years in the CDMO sector delivering innovative solutions and growing businesses.